Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine
about
Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenoneCarnitine Palmitoyltransferase 1b Deficiency Protects Mice from Diet-Induced Insulin ResistancePartial fatty acid oxidation inhibitors for stable angina.The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expressionMyocardial energy metabolism during ischemia and the mechanisms of metabolic therapies.Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease.Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.Perhexiline.Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.New directions in the treatment of heart failure: targeting free fatty acid oxidation.Structural insight into function and regulation of carnitine palmitoyltransferase.Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?Pleiotropic mechanisms of action of perhexiline in heart failure.Antilipolytic and antilipogenic effects of the CPT-1b inhibitor oxfenicine in the white adipose tissue of rats.Proteinase treatment of intact hepatic mitochondria has differential effects on inhibition of carnitine palmitoyltransferase by different inhibitors.A study of properties and abundance of the components of liver carnitine palmitoyltransferases in mitochondrial inner and outer membranes. Effects of hypothyroidism, fasting and a ketotic diabetic state.Effect of starvation and diabetes on the sensitivity of carnitine palmitoyltransferase I to inhibition by 4-hydroxyphenylglyoxylate.Cardiac lipoprotein lipase activity in the hypertrophied heart may be regulated by fatty acid flux.Regulation by oestrogen of carnitine palmitoyltransferase in hepatic mitochondriaEffects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic rats.Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin.Alterations in the regulatory properties of hepatic fatty acid oxidation and carnitine palmitoyltransferase I activity after ethanol feeding and withdrawal.Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.A low fat diet ameliorates pathology but retains beneficial effects associated with CPT1b knockout in skeletal muscle.What factors contribute to the elevation of serum free fatty acid levels in newborns in the cardiac surgical setting?Effects of fasting, hypoxia, methylpalmoxirate and oxfenicine on the tissue-levels of long-chain acyl CoA and acylcarnitine in the rat atria.Beneficial effects of oxfenicine on the hypoxic rat atria.Effects of oxfenicine on the atria from fed and fasted rats.
P2860
Q28361551-288DDEEE-8F13-44A8-B777-477E4588B0B8Q34307835-9E36A17A-9E2E-4E75-9C2F-40DEA0937445Q34628656-E5AA05A7-D65E-4977-9D42-7853B9C9FB1BQ35890670-86E08C6F-DFDB-44D1-BE13-250D676B465EQ35892161-2F4ECB28-4CBE-40A1-AFCB-C755C818DAC9Q36669174-EF9452AB-0078-4511-9D6B-6DCA93E8DA69Q36774157-B58FF25C-0272-4A08-A90D-0FCC5588758AQ36795930-0D5BE1BC-C56B-4FE4-BC6C-9AB12166DB55Q37012951-8EE3156C-C2CF-4ADF-B8CF-9DA8B0DF9AA0Q37067669-83314ADB-71ED-40B7-A2AA-265789A641C3Q37476799-A69BB86F-470F-454C-9752-F944AAFB11E6Q38126549-5BE42038-2AFB-4190-9102-39CA5590382AQ38907804-BD086AEE-2877-4006-BA46-968D605629BEQ41630738-332E7FE6-091E-4F1A-A847-6CAD66ABB008Q41788978-31863F49-8C73-4D67-BF7E-258D6B5B12CFQ41946080-DE377E2D-7DEE-4707-9BDF-787FF334DE2CQ42007940-CBD0C959-B849-47B2-AC7C-521EEF5D3D31Q42659033-D76472C2-3240-4FEC-A9B5-5D00A3FB3F96Q42854178-99A95D74-C4DE-4C69-8FCF-BBDB9E1350C2Q42949448-B74A42B5-2BD8-463A-B3FA-D228767C5A94Q43240756-F45E6CCE-4C7E-49BB-8A30-75A6A00A53EBQ43852717-B4F25C3A-DF9B-44D7-B0CF-70E299030F46Q44554639-28973BCC-BF8D-4492-94F0-CA0AD2E7105AQ46430416-5B8F9CF7-A752-4B54-859E-EA5D041AE01BQ47116575-332EE660-115E-462D-A0FB-2E6B1C3F5EB1Q50904747-3F43662E-D3C0-4C61-BB2F-2ECCF8E16988Q51570025-0C7681F1-54A2-4A19-8DE6-0FF17CA164B2Q51589437-2B34BCBA-F891-4DB5-A377-61828E6A47F4Q51596663-43B6BD52-5483-4069-8330-23E3486AD074
P2860
Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine
@en
type
label
Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine
@en
prefLabel
Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine
@en
P2093
P2860
P356
P1433
P1476
Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine
@en
P2093
A J Higgins
R A Harris
T W Stephens
P2860
P304
P356
10.1042/BJ2270651
P407
P577
1985-04-01T00:00:00Z